Literature DB >> 9533831

In vitro transplantation of fetal human retinal pigment epithelial cells onto human cadaver Bruch's membrane.

A A Castellarin1, I K Sugino, J A Vargas, B Parolini, G M Lui, M A Zarbin.   

Abstract

Retinal pigment epithelium transplantation has been proposed as adjunctive treatment for age-related macular degeneration following surgical excision of choroidal neovascular membranes. The goal of this study was to develop a model to evaluate retinal pigment epithelium transplantation onto human Bruch's membrane in vitro. We investigated the ability of cultured fetal human retinal pigment epithelium to colonize human cadaver Bruch's membrane, determined the incubation time needed to form a monolayer and to exhibit apical microvilli and tight junctions, and assessed the production of basement membrane. Freshly enucleated (less than 48 hours old) human eyes were cut through the pars plana, and the anterior segment, vitreous, and retina were removed. The native retinal pigment epithelium was debrided with a surgical sponge. Bruch's membrane and choroid at the macula were trephined with a 7.0 mm diameter trephine and then incubated with 1/2 ml of Dulbecco's modified Eagle's medium +15% fetal calf serum+basic fibroblast growth factor (1 ng ml-1), and fetal human retinal pigment epithelium at a concentration of 242,000 cells ml-1. Specimens were incubated for 1, 4, 6, 8, 12, or 24 hours. The specimens were fixed in half strength Karnovsky's fixative, processed, and analysed with scanning and transmission electron microscopy. The retinal pigment epithelium covered the debrided macular specimens to different degrees at different incubation times. After 1 hour, the cells started to attach and flatten (median percent coverage: 78%). The extent of Bruch's membrane coverage by fetal retinal pigment epithelium varied greatly between specimens. After 4-6 hours, the cells covered the entire debrided surface in a monolayer (median percent coverage: 97.2% at 4 hours, 99.8% at 6 hours). Tight junctions were observed, and the cells had few apical microvilli. The lateral cell borders were obliquely oriented with respect to Bruch's membrane, and the nuclei were elongated, exhibited prominent nucleoli, and were oriented parallel to Bruch's membrane. After 6-8 hours, cells started to become hexagonal (median percent coverage at 8 hours: 99.97%). Cells attached to the inner collagenous layer tended to be flatter than cells attached to residual native basement membrane. At 12 and 24 hours, expression of hexagonal shape, tight junctions, and apical microvilli were observed more frequently (median percent coverage: 99.87% at 12 and 100% at 24 hours). No newly formed basement membrane was observed at these time points. In separate experiments comparing attachment in the presence and absence of native RPE basement membrane, the presence of native retinal pigment epithelial basement membrane promoted the early attachment of the cells and more rapid expression of normal morphology. This in vitro system provides a reproducible way to study the adherence of retinal pigment epithelium to normal and diseased human Bruch's membrane. Copyright 1998 Academic Press Limited.

Entities:  

Mesh:

Year:  1998        PMID: 9533831     DOI: 10.1006/exer.1997.0404

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  13 in total

Review 1.  Basement membranes and artificial substrates in cell transplantation.

Authors:  Carl Sheridan; Rachel Williams; Ian Grierson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-20       Impact factor: 3.117

Review 2.  Fixation strategies for retinal immunohistochemistry.

Authors:  Tyler W Stradleigh; Andrew T Ishida
Journal:  Prog Retin Eye Res       Date:  2015-04-17       Impact factor: 21.198

Review 3.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane.

Authors:  Ilene K Sugino; Qian Sun; Jianqiu Wang; Celia F Nunes; Noounanong Cheewatrakoolpong; Aprille Rapista; Adam C Johnson; Christopher Malcuit; Irina Klimanskaya; Robert Lanza; Marco A Zarbin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

5.  Cell-deposited matrix improves retinal pigment epithelium survival on aged submacular human Bruch's membrane.

Authors:  Ilene K Sugino; Vamsi K Gullapalli; Qian Sun; Jianqiu Wang; Celia F Nunes; Noounanong Cheewatrakoolpong; Adam C Johnson; Benjamin C Degner; Jianyuan Hua; Tong Liu; Wei Chen; Hong Li; Marco A Zarbin
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-10       Impact factor: 4.799

Review 6.  Oxidative stress and mitochondrial transfer: A new dimension towards ocular diseases.

Authors:  Mohana Devi Subramaniam; Mahalaxmi Iyer; Aswathy P Nair; Dhivya Venkatesan; Sinnakaruppan Mathavan; Nimmisha Eruppakotte; Soumya Kizhakkillach; Manoj Kumar Chandran; Ayan Roy; Abilash Valsala Gopalakrishnan; Balachandar Vellingiri
Journal:  Genes Dis       Date:  2020-12-05

7.  Retinal pigment epithelium resurfacing of aged submacular human Bruch's membrane.

Authors:  Vamsi K Gullapalli; Ilene K Sugino; Yancy Van Patten; Sumit Shah; Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane.

Authors:  Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 9.  Age-related macular degeneration and retinal pigment epithelium wound healing.

Authors:  Ilene K Sugino; Hao Wang; Marco A Zarbin
Journal:  Mol Neurobiol       Date:  2003-10       Impact factor: 5.590

10.  Inner limiting membrane as membranous support in RPE sheet-transplantation.

Authors:  Julia Beutel; Lena Greulich; Matthias Lüke; Focke Ziemssen; Peter Szurman; Karl-Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.